Cost-Effective and Efficient Treatment
Affordable Treatment for Patients
Cancer treatments can be prohibitively expensive, leaving many patients unable to access the care they need. At CCTBH AB, we are proud to offer a solution that is not only effective but also affordable. The average cost of traditional breast cancer treatment in China ranges from 60,000 to 220,000 yuan (approximately 88,000 to 321,000 SEK). In contrast, the cost for patients using our PRFA technology is significantly lower, with treatments costing between 40,000 and 50,000 SEK.
Cost Efficiency for Healthcare Providers
Our PRFA Device is designed to be cost-effective for healthcare providers as well. Each machine costs approximately 75,000 SEK and has a lifespan of about five years. This long-term usability, combined with the low cost per treatment, makes the PRFA technology an excellent investment for hospitals and clinics seeking to provide advanced cancer care at an affordable price.
Lowering the Burden on Healthcare Systems
With cancer rates continuing to rise globally, healthcare systems are under increasing pressure to provide affordable, accessible treatments. The PRFA device is uniquely positioned to alleviate some of this burden by offering a treatment that is not only cheaper but also quicker, requiring fewer hospital resources and less patient recovery time. This efficiency allows hospitals to treat more patients without sacrificing the quality of care.
Scalability of Production
We have the capacity to scale up production to meet growing demand. With the potential to produce and deploy 50 machines per year, our PRFA device is ready to be implemented in healthcare facilities across the globe, offering a new standard of care for cancer patients.
